GlaxoSmithKline Faces Allegations in China

July 16 (Bloomberg) -- China is investigating at least four multinational drugmakers as it widens its probe of GlaxoSmithKline Plc, according to a lawyer in Hong Kong whose firm advises companies on cross-border anti-corruption. Olivia Sterns reports on Bloomberg Television's "Street Smart." (Source: Bloomberg)
The Top Stocks to Watch in Asia Today
07:40 - March 2 -- In today’s “Stock Exchange,” Bloomberg’s Yvonne Man, David Ingles and Zeb Eckert discuss the top three stocks to watch in Asia on “First Up."
  • Why Some See India's Budget as a Missed Opportunity
  • Hands-On: Samsung's Fancy New Galaxy S6, S6 Edge Phones
  • U.S. House Approves Stopgap DHS Funding Bill